COPD Therapeutics Market Share

Regionally, the global COPD therapeutics market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2031. Well-developed health care industry, comprehensive research & development, strong reimbursement policies as well as a large number of market key players in the region encouraging advanced and efficient products are factors expected to drive the COPD therapeutics market in the region during the forecast period. Furthermore, the increasing incidence of chronic obstructive pulmonary disease and asthma in the region along with the growing patient population is anticipated to drive the regional market over the forecast period. For instance, in 2020, there were 25,257,138 people suffering from asthma in the region. In addition, in 2018, chronic lower respiratory disease (COPD) ranked as the fourth leading cause of death in the United States. There were almost 15.7 million Americans (6.4%) who have been affected by COPD in 2018.